Abstract: The present disclosure provides a method for scheduling a physical sidelink resource. The method may comprise selecting, among a plurality of modes for physical sidelink resource selection, a first mode for the apparatus to assist a plurality of wireless user devices to select at least one physical sidelink resource, wherein the first mode is different from a second mode for the apparatus to automatically select at least one second physical sidelink resource and different from a third mode for the apparatus to perform sidelink transmission on a pre-configured physical sidelink resource, transmitting, to the plurality of wireless user devices, information to schedule a resource for sidelink communication of the plurality of wireless user devices, and receiving, from at least one wireless user device of the plurality of wireless user devices, SCI via a physical sidelink resource selected by the at least one wireless user device.

Abstract: Disclosed is a nonthermal plasma-based exhaust gas particulate matter reduction apparatus for preventing an arcing phenomenon, the apparatus comprising: a chamber which is a tubular body having exhaust gas flowing therein and is connected to a ground power supply; a power supply device which is disposed outside the chamber and includes a voltage generation unit for generating a steady-state voltage at which maximum efficiency of a nonthermal plasma phenomenon is generated; an emitter which is disposed inside the chamber and generates nonthermal plasma between the chamber by having the steady-state voltage applied thereto; a rod which applies the steady-state voltage to the emitter by electrically connecting the voltage generation unit and the emitter; and an arcing prevention unit which prevents an arcing phenomenon from occurring between the rod and the chamber by providing insulation between the rod and the chamber.

Abstract: An organic light-emitting element according to the present invention employs a polycyclic aromatic derivative compound in a light-emitting layer inside the element, and further comprises a capping layer. Thus, the organic light-emitting element can be made highly efficient and can be useful for a device selected from among a flat panel display device, a flexible display device, a monochrome or white flat panel lighting device, and a monochrome or white flexible lighting device.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: A secondary battery includes: a first electrode plate including a first substrate having a first active material coated portion coated with a first active material and a first electrode uncoated portion not coated with the first active material; a second electrode plate including on a second substrate having a second active material coated portion coated with a second active material and a second electrode uncoated portion not coated with the second active material; a separator between the first electrode plate and the second electrode plate; an electrode tab connected to one of the first electrode uncoated portion and the second electrode uncoated portion; an insulation tape on the first electrode uncoated portion or the second electrode uncoated portion and covering the electrode tab; and a step compensation unit on a region of an upper surface of the insulation tape excluding a region corresponding to the electrode tab.

Abstract: A secondary battery includes a first electrode plate including a first substrate having a first active material coated portion coated with a first active material and a first electrode uncoated portion not coated with the first active material; a second electrode plate including a second substrate having a second active material coated portion coated with a second active material and a second electrode uncoated portion not coated with the second active material; a separator between the first electrode plate and the second electrode plate; an electrode tab connected to one of the first electrode uncoated portion and the second electrode uncoated portion; and an insulation member that covers the electrode tab and fixes the electrode tab to the first electrode plate or the second electrode plate. The insulation member has a non-adhesive region on one side at a position corresponding to the electrode tab and an adhesive area.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of inflammatory disease, comprising mesenchymal stem cells expressing PTX-3, TIMP1, and BDNF as an active ingredient. The mesenchymal stem cells expressing PTX-3, TIMP1, BDNF, and/or HLA-A2, according to the present invention, may inhibit an inflammatory response by reducing the expressions of the inflammatory cytokines IL-1b, IL-6, IL-8, and TNF-a, and increasing the expressions of the anti-inflammatory cytokines IL-10 and arginase-1 (ARG-1), and may relieve pain caused by osteoarthritis when administered in an osteoarthritis-induced rat. Thus, the mesenchymal stem cells expressing PTX-3, TIMP1, and BDNF of the present invention may be usefully employed in the prevention, alleviation, or treatment of inflammatory disease, pain, and pain cuased by inflammation.

Abstract: A secondary battery including an electrode assembly; a case containing the electrode assembly; and a strip terminal including a conductor part connected to the electrode assembly and extending outward, a foaming part surrounding the conductor part and containing foaming particles that foam under predetermined temperature conditions, and an adhesive layer surrounding the foaming part and bonded to the case.

Abstract: Provided is a method and apparatus for performing a random access procedure. A wireless device may transmit a random access preamble and may monitor for a random access response. The wireless device may determine to transmit a second random access preamble or to transmit uplink data responsive to the random access response. A time for preparing the second random access preamble may be determined based on a subcarrier spacing associated with the random access preamble or a subcarrier spacing associated a downlink channel associated with the random access response. A time for preparing the uplink data may be determined based on a subcarrier spacing associated with the uplink data or a subcarrier spacing associated a downlink channel associated with the random access response.

Abstract: The present disclosure provides a method for performing HARQ retransmission by a terminal supporting V2X communication in a wireless communication system. The method for performing HARQ retransmission may comprise the steps of: transmitting data by a transmission terminal in a pre-configured resource; receiving, by the transmission terminal, a NACK response to the data from a reception terminal; and retransmitting the data by the transmission terminal after changing an NDI value based on a resource dynamically allocated from a base station.

Abstract: Proposed is a composition for preventing or treating lung diseases. The composition may contain CD47-overexpressing mesenchymal stem cells as an active ingredient. CD47-overexpressing mesenchymal stem cells, even when not autologous, show a high survival rate in vivo and the ability to migrate to lung tissue, reduce the inflammatory response in lung tissue, and exhibit a fibrosis-inhibiting effect. CD47-overexpressing mesenchymal stem cells can be widely used for the prevention or treatment of various lung diseases related to inflammation or fibrosis of the lungs.

Abstract: An object of the present invention is to provide a material for organic EL elements, the material being excellent in hole injecting/transporting performance, electron-blocking capability, stability in the form of a thin film, and durability. Another object of the present invention is to provide an organic EL element having high efficiency, a low driving voltage, and a long lifespan, by combining the aforementioned material with various materials for organic EL elements, the materials being excellent in hole/electron injecting/transporting performance, electron-blocking capability, stability in the form of a thin film, and durability, such that the properties of the individual materials can be effectively exhibited.

Abstract: The present disclosure relates to a TIS-L targeting antisense oligonucleotide that inhibits the viral replication of SARS-COV-2 and antiviral use thereof. Since the TIS-L targeting antisense oligonucleotide according to the present disclosure has a simple structure, it is easy to mass produce, and as it exhibits antiviral efficacy of 90% or more even at low doses against the original strain and various modified strains of the virus, it can be advantageously utilized in the development of COVID-19 treatment.

Abstract: The present invention relates to a novel polycyclic compound employed in an organic layer of an organoelectro luminescent device, wherein the organoelectro luminescent device employing the compound according to the present invention has remarkably improved luminous efficiency and a long lifespan. According to the present invention, it is possible to implement a highly efficient and long-life organoelectro luminescent device that can be effectively applied to various display devices.

Abstract: It is an object of the present invention to provide a compound that has a high refractive index and a low extinction coefficient in a wavelength range of 450 to 750 nm, which is favorably used as a material for a capping layer of an organic EL element. Also, it is another object of the present invention to provide an organic EL element whose light extraction efficiency has been improved by using the compound. The present invention is directed to a compound represented by a general formula (1) or (2) below: where A represents a substituted or unsubstituted aromatic hydrocarbon group or the like, B and C are optionally the same or different, and represent an unsubstituted naphthyl group, an unsubstituted quinolyl group, or the like, and each L is optionally the same or different, and represents a single bond, a substituted or unsubstituted divalent aromatic hydrocarbon group, or the like.

Abstract: Apurinic/apuyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) inhibitors are provided along with methods of using the same. The inhibitor has the structure of Formula I: or a pharmaceutically acceptable salt thereof. n is an integer from 4 to 14, X and X? are each independently H or OH, and Y and Y? are each independently H or OH.

Abstract: In order to prevent deterioration inside an organic EL element and significantly improve the light extraction efficiency, an object of the present invention is to provide a compound that absorbs light rays with wavelengths of 400 to 410 nm of sunlight, thereby preventing them from affecting a material inside the element, and has a high refractive index in a wavelength range of 450 to 750 nm. The present invention provides an amine compound having a specific benzazole ring structure having a high refractive index. An organic EL element having excellent light emission efficiency is obtained by using the compound of the present invention as a material constituting a capping layer.

Abstract: The present disclosure provides a method for performing HARQ retransmission by a terminal supporting V2X communication in a wireless communication system. The method for performing HARQ retransmission may comprise the steps of: transmitting data by a transmission terminal in a pre-configured resource; receiving, by the transmission terminal, a NACK response to the data from a reception terminal; and retransmitting the data by the transmission terminal after changing an NDI value based on a resource dynamically allocated from a base station.

Abstract: The present invention relates to a novel polycyclic compound employed by an organic layer of an organic light-emitting device, and an organic light-emitting device employing the compound according to the present invention has markedly improved luminous efficiency. According to the present invention, it is possible to achieve a highly efficient organic light-emitting device which can be effectively applied to a variety of display devices.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.